Skip to main content

Table 4 Planned dose in targets

From: Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer

  

PSV-PCTV

PCTV-PGTVs

 

PGTVs

Patient

Plan

Prescription

Inhomogeneity

Conformity

Prescription

Inhomogeneity

Conformity

Prescription

Inhomogeneity

Conformity

Volumea

D min b

D max b

D mean c

IC

CN

Volume

D min b

D max b

D mean c

IC

CN

Volumea

D min b

D max b

D mean c

IC

CN

1

Proton

99.1 %

97.2 %

180.2 %

68.1

0.614

0.043

99.3 %

97.7 %

132.9 %

83.5

0.296

0.342

98.9 %

99.2 %

103.8 %

91.9

0.045

0.189

IMRT

99.1 %

95.6 %

152.2 %

63.6

0.448

0.048

99.3 %

96.2 %

133.0 %

82.1

0.316

0.404

98.9 %

98.8 %

107.0 %

93.3

0.079

0.319

2

Proton

99.3 %

99.0 %

180.0 %

70.1

0.582

0.039

98.8 %

98.3 %

132.9 %

85.1

0.285

0.328

98.4 %

99.7 %

103.8 %

91.2

0.041

0.197

IMRT

99.3 %

96.6 %

158.1 %

64.1

0.484

0.043

98.8 %

96.2 %

134.0 %

82.7

0.322

0.422

98.4 %

96.3 %

108.2 %

93.5

0.114

0.336

3

Proton

98.5 %

95.0 %

165.7 %

66.8

0.533

0.049

98.5 %

99.3 %

131.1 %

80.7

0.276

0.431

98.2 %

99.4 %

102.2 %

91.1

0.027

0.189

IMRT

98.5 %

95.6 %

148.4 %

62.2

0.428

0.052

98.5 %

95.3 %

133.9 %

81.0

0.334

0.542

98.2 %

96.8 %

106.2 %

93.3

0.091

0.286

4

Proton

99.4 %

97.8 %

178.2 %

67.0

0.604

0.076

99.3 %

97.2 %

132.3 %

84.1

0.294

0.397

98.8 %

99.2 %

103.3 %

91.2

0.041

0.215

IMRT

99.4 %

98.0 %

155.6 %

62.4

0.465

0.076

99.3 %

95.7 %

133.6 %

82.9

0.321

0.443

98.8 %

97.3 %

108.4 %

93.9

0.106

0.346

5

Proton

99.4 %

95.4 %

181.7 %

72.9

0.597

0.054

99.1 %

98.6 %

132.3 %

84.5

0.281

0.323

98.7 %

98.9 %

103.9 %

91.4

0.049

0.221

IMRT

99.4 %

96.8 %

152.6 %

64.9

0.433

0.069

99.1 %

95.0 %

135.5 %

81.0

0.350

0.491

98.7 %

97.3 %

108.8 %

94.5

0.109

0.459

6

Proton

98.6 %

96.0 %

183.5 %

71.3

0.619

0.054

99.2 %

98.3 %

134.2 %

83.5

0.302

0.193

99.3 %

99.7 %

104.8 %

92.2

0.050

0.219

IMRT

98.6 %

95.2 %

166.9 %

65.1

0.554

0.055

99.2 %

96.3 %

134.9 %

80.4

0.337

0.220

99.3 %

98.9 %

106.6 %

93.1

0.074

0.386

7

Proton

98.9 %

98.2 %

181.9 %

72.7

0.581

0.056

99.6 %

99.3 %

134.2 %

85.7

0.286

0.281

98.5 %

98.4 %

103.9 %

92.0

0.053

0.237

IMRT

98.9 %

95.2 %

177.2 %

63.4

0.652

0.051

99.6 %

96.9 %

137.0 %

81.4

0.347

0.313

98.5 %

97.9 %

110.0 %

95.3

0.114

0.415

8

Proton

98.8 %

95.4 %

172.0 %

65.6

0.589

0.069

99.3 %

98.1 %

135.9 %

84.8

0.313

0.313

99.0 %

99.4 %

107.3 %

92.0

0.077

0.218

IMRT

98.8 %

96.4 %

158.5 %

63.1

0.496

0.074

99.3 %

96.6 %

134.5 %

81.0

0.328

0.346

99.0 %

99.1 %

108.2 %

94.0

0.087

0.341

9

Proton

98.2 %

92.5 %

183.7 %

72.8

0.632

0.063

99.5 %

97.9 %

132.6 %

86.6

0.282

0.259

99.3 %

99.4 %

103.3 %

91.9

0.038

0.255

IMRT

98.2 %

97.2 %

168.8 %

64.2

0.562

0.060

99.5 %

98.0 %

136.8 %

83.5

0.326

0.268

99.3 %

99.0 %

106.8 %

93.7

0.075

0.349

10

Proton

99.3 %

96.4 %

143.7 %

65.5

0.363

0.012

99.6 %

99.0 %

132.2 %

80.4

0.290

0.414

98.0 %

99.6 %

103.3 %

91.3

0.037

0.221

IMRT

99.3 %

99.2 %

148.8 %

64.9

0.385

0.012

99.6 %

95.9 %

136.5 %

80.6

0.354

0.477

98.0 %

96.6 %

108.7 %

94.2

0.116

0.341

  1. aMinimum volume to which prescribed dose is planned
  2. bRelative to the prescribed dose in percent
  3. cIn Gy